Search research articles
Contact Us
Filters
Showing results (491-500 of 818) with videos related to
Page
of 82
Sort By:
The Laryngoscope
|
October 15, 2013
Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer
John A Vargo, Gregory J Kubicek, Robert L Ferris, et al.
Oral Oncology
|
April 17, 2014
Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells
Heng-Wei Hsu, Rosalia de Necochea-Campion, Vonetta Williams, et al.
Immunity
|
September 23, 2016
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E Scharping, Ashley V Menk, Rebecca S Moreci, et al.
Ophthalmology
|
September 18, 2003
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study
Emily Y Chew, Frederick L Ferris, Karl G Csaky, et al.
Immunity
|
August 7, 2016
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E Scharping, Ashley V Menk, Rebecca S Moreci, et al.
Psychonomic Bulletin & Review
|
August 19, 2007
Retrograde facilitation under midazolam: the role of general and specific interference
Lynne M Reder, Joyce M Oates, Daniel Dickison, et al.
Journal of Virology
|
December 14, 2018
Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions
Tatiana M Garcia-Bates, Mariana L Palma, Chengli Shen, et al.
Cancer Immunology Research
|
May 15, 2015
STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients
Raghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al.
Future Oncology (London, England)
|
January 10, 2024
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design
Robert L Ferris, Hisham Mehanna, Jonathan D Schoenfeld, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
August 5, 2000
The carbenoid approach to peptide synthesis
R T Buck, P A Clarke, D M Coe, et al.
Page
of 82
Search research articles
Search
Showing results (491-500 of 818) with videos related to
Sort By:
Page
of 82
The Laryngoscope
|
October 15, 2013
Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer
John A Vargo, Gregory J Kubicek, Robert L Ferris, et al.
Oral Oncology
|
April 17, 2014
Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells
Heng-Wei Hsu, Rosalia de Necochea-Campion, Vonetta Williams, et al.
Immunity
|
September 23, 2016
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E Scharping, Ashley V Menk, Rebecca S Moreci, et al.
Ophthalmology
|
September 18, 2003
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study
Emily Y Chew, Frederick L Ferris, Karl G Csaky, et al.
Immunity
|
August 7, 2016
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E Scharping, Ashley V Menk, Rebecca S Moreci, et al.
Psychonomic Bulletin & Review
|
August 19, 2007
Retrograde facilitation under midazolam: the role of general and specific interference
Lynne M Reder, Joyce M Oates, Daniel Dickison, et al.
Journal of Virology
|
December 14, 2018
Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions
Tatiana M Garcia-Bates, Mariana L Palma, Chengli Shen, et al.
Cancer Immunology Research
|
May 15, 2015
STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients
Raghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al.
Future Oncology (London, England)
|
January 10, 2024
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design
Robert L Ferris, Hisham Mehanna, Jonathan D Schoenfeld, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
August 5, 2000
The carbenoid approach to peptide synthesis
R T Buck, P A Clarke, D M Coe, et al.
Page
of 82